The global Peptide Active Pharmaceutical Ingredients (API) market is poised for explosive growth, with its valuation expected to surge from US$ 9.2 Bn in 2023 to over US$ 94.2 Bn by 2034, expanding at a CAGR of 22.4% during the forecast period. This expansion is propelled by the increasing global burden of chronic diseases, particularly diabetes and obesity, coupled with the rising adoption of...